Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline
2024; Elsevier BV; Volume: 14; Issue: 5 Linguagem: Inglês
10.1016/j.prro.2024.05.007
ISSN1879-8519
AutoresDanielle N. Margalit, Christopher J. Anker, Michalis Aristophanous, Musaddiq Awan, Gopal Bajaj, Lisa Bradfield, Joseph Califano, Jimmy J. Caudell, Christina Chapman, Adam S. Garden, Paul M. Harari, Amanda Helms, Alexander J. Lin, Ellie Maghami, Ranee Mehra, L M Parker, Yelizaveta Shnayder, Sharon Spencer, Paul Swiecicki, Jillian Tsai, David J. Sher,
Tópico(s)Lung Cancer Diagnosis and Treatment
ResumoHuman Papilloma Virus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is a distinct disease from other head and neck tumors. This guideline provides evidence-based recommendations on the critical decisions in its curative treatment, including both definitive and postoperative radiation therapy (RT) management.
Referência(s)